RESEARCH TRIANGLE PARK, N.C., Oct. 30 QuintilesTransnational Corp. today announced that its Latin American subsidiary haspurchased Bio-Trials, a leading Central American Clinical ResearchOrganization (CRO) with headquarters in Panama and offices in Costa Rica,Guatemala, Ecuador and Peru.
Bio-Trials provides clinical monitoring, clinical site coordination,regulatory support, study management and supply distribution services. It hasconducted about 30 clinical trials in 10 Central and South American countries,and its customers have included a number of major pharmaceutical companies andglobal CROs.
"The acquisition of Bio-Trials gives Quintiles an experienced, well-established team as well as access to an experienced network of independentinvestigators in the increasingly important Central American region," saidJeff Thomis, President of Global Clinical Development Services for Quintiles."Our customers are increasingly including Central America as part of theirglobal drug development program. The Bio-Trials team will be a welcomeaddition to our Latin America group."
In addition to its offices, Bio-Trials has supply distribution points inPanama, Costa Rica, Guatemala and Peru.
About Quintiles Latin America
Quintiles Latin America was founded in 1995 and now has nearly 600employees in six countries, with headquarters in Argentina, providing projectmanagement, clinical trial monitoring, regulatory, drug safety, sitemanagement, quality assurance, central laboratory and clinical trial suppliesservices. Quintiles Latin America has conducted more than 300 studiesinvolving more than 30,000 patients.
About Quintiles Transnational
Quintiles Transnational Corp. is powering the next generation ofhealthcare by providing a broad range of professional services in drugdevelopment, financial partnering and commercialization for thepharmaceutical, biotechnology and healthcare industries. With more than 19,000employees and offices in more than 50 countries, it is focused on providingcustomer-centric solutions that are the gold standard of the industry. Formore information, please visit the company's Web site at www.qtrn.com.
SOURCE Quintiles Transnational Corp.